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ABSTRACT: The clinical-rated and self-rated versions of the Apathy Evaluation Scale 
are validated for English language. The Apathy Evaluation Scale is useful to characterize 
and quantify apathy. We analyzed the metric properties of the Portuguese version of the 
Apathy Evaluation Scale-Clinical and of a new 10-item short version of the clinical-rated 
and self-rated versions Apathy Evaluation Scale. We included, 156 “healthy participants”, 
40 healthy “elderly participants”, 21 patients with dementia, and 21 patients with 
depression, comprising a sample of 238 individuals. We studied reliability using 
Cronbach Alpha (α) and Split-half method, and construct validity using principal 
component analysis with Varimax rotation. The clinical-rated and self-rated Portuguese 
versions of the AES are valid instruments to measure apathy in Portuguese speaking 
individuals. Both the clinical-rated and the self-rated versions Apathy Evaluation Scale 
can be used instead of the long versions of the Apathy Evaluation Scale. 
Key words- Apathy, Depression, Motivation, Neuropsychiatry, Psychometric, Mood, 
Aboulia 
________________________________________________________________ 
RESUMO: As versões clínica e de auto-avaliação da Escala de Avaliação da Apatia 
estão validadas na versão original inglesa. A Escala de Avaliação da Apatia é utilizada 
para caracterizar e quantificar a apatia. Nós analisámos as propriedades métricas das 
versões portuguesas da Escala de Avaliação da Apatia, e também de uma versão reduzida 
da escalas clínica e de auto-avaliação , mas com apenas 10-items. Incluímos 156 
“participantes saudáveis”, 40 “participantes idosos saudáveis”, 21 pacientes com 
demência, e 21 pacientes com depressão, fazendo uma amostra total de 238 indivíduos. 
Estudámos o nível de fidelidade suportado pelo Alpha (α) de Cronbach e com o método 
Split-half, e a validade de construto através da análise dos componentes principais com 
rotação de Varimax. Na sua versão Portuguesa, tanto a Escala de Avaliação da Apatia 
clínica como a de auto-avaliação são instrumentos válidos para medir a apatia em sujeitos 
portugueses. As versões clínica e de auto-avaliação reduzidas de 10-items podem ser 
utilizadas em substituição das versões mais longas da Escala de Avaliação da Apatia. 
Palavras Chave- Apatia, Depressão, Motivação, Neuropsiquiatria, Psicométrico, Humor, 
Aboulia 
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Apathy is a lack of motivation with simultaneous decrease in behavioural, cognitive and 
emotional concomitants of goal-direct behaviour (Marin, 1991; Marin, Biedrzycki & 
Firinciogullari, 1991) which could lead to an “indifference and lack of response to one’s 
surroundings” (American Psychological Association, 2007, pp. 65). Apathy is a 
neurobehavioral syndrome and may comprise aboulia (an extreme loss of will, but expressed 
by an absence/reduction of spontaneous acting, and thinking), avolition (failure to engage in 
goal direct-behaviour), athymormia (loss of motor and/or affective auto-activation but not of 
heteroactivation), and/or affective indifference to any stimulus (American Psychiatric 
Association  (APA), 2002; Marin et al., 1991; Marin, 1990; Sadock & Sadock, 2003). Thus, 
for the evaluation of apathy it is important to ask for motivation but also observe behaviour, 
cognition and emotional responses (Marin et al. 1991). 
Apathy secondary to a medical condition such as in schizophrenia, depression, 
Alzheimer’s dementia, vascular dementia or fronto-temporal dementia, Parkinson’s disease, 
and stroke, was defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-
IV-TR) (APA, 2002) as a personality disturbance. Apathy interferes with a patient’s ability to 
fulfil daily and social activities (Iancu, Tschernihovsky, Bodner, Piconne, & Lowengrub, 
2010). If patients start rehabilitation programs the Apathy Evaluation Scale (AES) may be 
used for monitorization (Resnick, Zimmerman & Adelman, 1998). 
The original English version of the AES was developed and validated by Marin et al. 
(1991). The original AES aimed to characterize and quantify apathy in patients older than 55 
years old, with the AES clinical-rate (AES-C), AES self-rated (AES-S) and AES informant 
rate, in a healthy sample and in samples of patients with depression or dementia. For the 
principal components, factor analysis Marin et al. (1991) identified three factors. Internal 
consistency was high for the clinical rate (coefficient α=.90) and for the self-rated version 
(coefficient α=.86) (Marin et al. 1991). The two versions were highly correlated (r=.72, 
p=<.01). Following the Marin et al. (1991) publication, data from 31 healthy controls revealed 
that participants would be apathetic if scoring a mean of 26 points,  (SD= 6.2), in the AES-C 
and a mean of 28.1 points, (SD=f 6.4), in the AES-S. 
The AES was validated in Chinese and German languages (Lee, Wen, Chao, Chen & Yen, 
2008; Lueken et al., 2006). Lee et al. (2008) showed that the Chinese version of the AES-C 
had high internal consistency (Cronbach α=.90). For the Chinese sample of 31 normal 
individuals, a mean of 27.9 points, (SD = 7.6), in the AES-C would identify apathetic 
patients. Lueken et al. (2006) reported high internal consistency for the German version of the 
AES-C and AES-S (Cronbach α≥.92). In this German publication, based on data from 37 
controls, participants would be apathetic if they scored a mean of 20.2, (SD= 2.7), in the 
AES-C, and a mean of 23.5, (SD = 5.8), in the AES-S. The use of the AES was extended to 
neurologic and psychiatric disorders; Sagen, Faerden, Haug, Melle, Finset, & Dammen (2010) 
studied factor structure of the Norwegian version of the AES-S in 85 stroke patients and of 
the AES-C in 76 subarachnoid haemorrhage patients, and of both scales in 104 psychotic 
patients and Lane-Brown and Tate (2009) validated AES-C in 34 patients with severe 
traumatic brain injury. 
More recently, Lueken et al. (2007) validated a short version of the AES, with items 1 to 4, 
6 to 9, 17 and 18, in 356 demented nursing home residents. This short version identified 
apathetic patients if they had a mean of 14.7 points, (SD = 9.8). Sagen et al. (2010) studied 
factor structure of a second 10-item version of the AES, with items 1, 2, 4 to 7, 9, 16 to 18, in 
the follow-up of stroke, subarachnoid haemorrhage and psychotic patients. However, these 
short versions were not adequate for patients in an acute hospital setting. In the Neurology 
Service of Hospital Santa Maria in Lisbon, we evaluate acute neurologic patients, and because 
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some of the AES items are not appropriate for a context as a hospital ward for acute patients, 
we develop a new short version of the AES. 
The first aim of this study was to analyze the metric properties of the clinical-rated and 
self-rated Portuguese version of the AES. The second aim of this study was to analyze the 
metric properties of a clinical-rated and self-rated 10-item version scale of the AES. 
 
METHOD 
Participants 
We included two groups of participants which were a) caregivers of patients attending the 
Neurologic Outpatient Clinic (“Healthy participants”) aged between 18-80 years old, and b) 
subjects older than 60 years old from a Day Centre for the elderly (“Elderly participants”). 
Inclusion criteria for “healthy participants” and “elderly participants” were: 1) independent 
in daily activities, 2) fluency in Portuguese and understanding the purpose of the study, 3) 
living anywhere in Portugal. Exclusion criteria for “healthy participants” and “elderly 
participants” were the presence of any psychiatric disorder or of a cognitive impairment, 
based on the DSM-IV-TR clinical criteria (APA, 2002). 
We also included two groups of patients that were: a) patients attending the Dementia 
Outpatient Clinic (“Dementia patients”), and b) patients attending the Psychiatric Outpatient 
Clinic (“Depression patients”), at the Hospital Santa Maria in Lisbon. 
Inclusion criteria for “demented” or “depressive patients” were: 1) having an exclusive 
diagnosis of mild Alzheimer’s dementia or of mild cognitive impairment for the “dementia 
group”, or 2) having an exclusive diagnosis of major depressive disorder or of a dystimic 
disorder based on the DSM-IV-TR clinical criteria (APA, 2002) for the “depressive group”, 3) 
fluency in Portuguese, 4) understanding the purpose of the study, 5) older than 50 years old 
for the “dementia group” and older than 18 years old for the “depression group”, and 6) living 
anywhere in Portugal. 
Both participants and patients were invited to participate in the study and gave their 
informed consent. The Ethics Committee of the Faculty of Medicine, University of Lisbon, 
approved the study. 
A total sample of 238 individuals voluntarily participated in this study and included 156 
“healthy participants” and 40 “elderly participants”, 21 patients with “dementia” and 21 
patients with “depression”. (Table 1) 
As expected “elderly participants” and “dementia patients” were older than “healthy 
participants” and “depression patients” (F(3,237)=47.1, p=.0001; Bonferroni p<.001). Women 
formed the majority in the group of patients with “depression” and were less frequent in the 
group of patients with “dementia” (χ2(3)=9.93, p=.02). 
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Table 1: Demographic characteristics of “participants” and “patients” included in each 
group to evaluate the clinical-rated and self-rated versions of the AES 
 
 
MeanSD: meanstandard deviation. AES: Apathy Evaluation Scale-Clinical. AES-C: Apathy Evaluation 
Scale-Clinical. AES-S: Apathy Evaluation Scale-Self-rated. AES-C-10: 10-item Apathy Evaluation Scale-
Clinical-10. AES-S-10: 10-item Apathy Evaluation Scale-Self-rated-10. 
 
Apathy Evaluation Scale 
 The AES is an 18-item scale developed by Marin et al. (1991). The clinical rate (AES-C) 
and self-rated (AES-S) versions of the AES have 18 items each. Responses to each item can 
be “Not at all characteristic” (4 points), “Slightly characteristic” (3 points), “Somewhat 
characteristic” (2 points) or “Very characteristic” (1 point). Items 6, 10 and 11, as negative 
sentences were scored as “Not at all characteristic” (1 point), “Slightly characteristic” (2 
points), “Somewhat characteristic” (3 points) or “Very characteristic” (4 points). Marin et al. 
(1991) defined that a higher total score indicated greater severity of apathy, ranging from a 
minimum of 18 points and a maximum of 72 points. 
AES: Adaptation to the Portuguese language - A professional translator translated the 
English version of the AES-C to Portuguese, and another professional translator translated 
this Portuguese version into English. The final Portuguese and the corresponding English 
translations were e-mailed to the original author (Prof. RS Marin) to obtain his approval 
(Appendix 1). The author approved the translation of the 18-item AES-C version. 
 
Construction and adaptation to the Portuguese language of a short version of the AES 
Most of the patients admitted to an acute care hospital have a short stay. During their 
hospitalization, patients cannot answer if they “do things”, if they like to “start” or “finish” 
things, because they have to follow the hospital routine and pathways of care. Therefore, we 
excluded those items from the AES that we considered not to be appropriate for assessing 
apathy in an acute hospital setting (items 2, 3, 4, 5, 7, 8, 9 and item 16). For the adaptation of 
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the 18-item scale into a 10-item version, we kept the same order of the items: item 1 was kept 
as item 1, item 6 was changed to item 2, 10 to 3, 11 to 4, 12 to 5, 13 to 6, 14 to 7, 15 to 8, 17 
to 9, and item 18 to item 10. The items selected for the clinical-rated version (AES-C-10) 
were the same as those included in the self-rated version (AES-S-10). As in the Lueken et al. 
(2007) validation publication, we also excluded items 5 and 16 and as in the Sagen et al. 
(2010) validation publication we excluded item 3 and 8. Lueken et al. (2007) and Sagen et al. 
(2010) excluded items 10, 11, 12, 13, 14 and 15, but we retained these items because we 
thought that for acute patients “being interested” about and “understand” their medical 
condition, “getting excited” with good things, such as the improvement of their medical 
condition, and maintaining their interest in “friends” and in getting their attention during their 
stay in the hospital, would provide good information about their motivation, or about the 
possible presence of indifference or even about their engagement in getting healthier. The 
common items in the 3 versions of a short AES were item 1 (Interested in things), item 6 
(Little effort in anything), item 17 (Has initiative) and item 18 (Has motivation). 
 
Procedure 
“Healthy” and “elderly participants”, “dementia” and “depression patients” were 
interviewed by two psychologists who performed a psychological and cognitive evaluation. 
For this purpose, we used the clinical information from the Day Centre file of each “elderly 
participant” and the Montgomery Ǻsberg Depression Rating Scale (MADRS) (Montgomery 
and Asberg, 1979) to assess depression. The Mini-Mental State Examination (MMSE) 
(Guerreiro, Silva, Botelho, Leitão, Castro-Caldas & Garcia, 1994) was used to assess 
cognition in “healthy participants” and “elderly participants” and in “dementia” and 
“depression patients”. After being assessed for apathy with the AES-C “participants” and 
“patients” filled in the AES-S. If the “participants” or “patients” could not read (due to vision 
problems or being illiterate) the psychologist would read the questions from the AES-S, 
asking for a No (“Not at all characteristic”) or Yes response, and if Yes either “Slightly 
characteristic”, “Somewhat characteristic” or “Very characteristic”. 
 
Statistical Analysis 
Bivariate analyses, comparing scores between 2 or all 4 samples, among the “healthy”, 
“elderly”, “dementia” and “depression” samples of subjects, were performed using ANOVA 
(F) with Bonferroni adjustment and independent t-test (t). The correlation between continuous 
variables was performed using Pearson correlation (r) analysis. 
The answers given by the sample of 156 “healthy participants” were used for additional 
statistical analysis: 1) Construct validity by factor analysis of principal components with 
Varimax rotation, the extraction of three factors (we forced number three) and inspection of 
the screen plot of rotation values. 2) Internal consistency or reliability evaluation using a) 
Cronbach Alpha (α) and b) Split-half reliability, where results would show good inter-item 
correlation if α>.65. 3) Standardization: the cut-off point, which was the highest value 
following the value obtained by the mean plus two standard deviations (Z-score: mean+2SD), 
as proposed by Streiner and Norman (2003). Apathy was present if subjects scored the value 
of the cut-off point or above. 4) Categorization of age in three age groups: young (18-40), 
middle aged (40-65) and older subjects (65-80). 5) Educational levels categorized in the three 
groups of mandatory school education: low educational level (≤4 years of school), mean 
education (5-9 years of school) and high education (≥10 years of school). 
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Analysis was performed using the SPSS software and a two-tailed p-value of ≤ .05 was 
considered statistically significant. 
 
 
 
RESULTS 
Metric properties of the AES-C 
We included the sample of 156 “healthy participants” which constituted a random 
sequential sample of individuals without any psychiatric or neurological disease or daily 
living activities and who were caregivers of users of Neurologic Outpatient Clinic. 
Internal consistency coefficient was high with a Cronbach α=.82 and a Split-half α=.67 
(Between the 18 items: F(17,155)=27.55, p< .01). For the principal component analysis 
(PCA) we did not exclude any items from the scale because they all had high values of > .40. 
Item component distribution is similar to the original version. The three components (Kaiser 
Rule) accounted for 47.3% of the variance (Table 2).  
 
Table 2: The three PCA (Kaiser Rule) for the 18-version of the AES-C and AES-S 
(Rotated Component Matrix) 
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The three components were inter-correlated (Table 3). AES-C was highly correlated with 
components 1 and 2 and moderately correlated with component 3 (Table 3). 
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Table 3: Pearson’s correlation (r) among the three components and between each of these 
and the AES, in the “healthy Participants” sample (n=156) 
 
 
There were no differences in AES-C scale scores between genders (t(154)=0.33, p>.05) 
and among the three age groups (F(2, 155)=1.94, p>.05). There was a weak negative 
correlation between AES-C and educational level (r=-.32, p<.01) and we found some 
differences (F(2,155)=11.54, p<0.01; Bonferroni p<.03) among the three educational groups, 
with the lowest (</=4 years and 5-9 years of school) educated groups having higher cut-off 
points on the AES-C (Table 4).  
 
Table 4: Cut-off points of the AES-C and AES-C-10, based on educational levels, in the 
“healthy Participants” sample (n=156) 
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The cut-off point for the AES-C, independently of educational level, was 35 (Table 5) and 
participants scoring above would be considered as being apathetic (Eleven (5.1%) participants 
scored above). 
 
Table 5: Metric characteristics of the AES and AES-10 
 AES-C 
“Healthy 
participants” 
(n=156) 
AES-S 
“Healthy 
participants” 
(n=143) 
AES-C 
“Elderly 
participants” 
(n=40) 
AES-C 
“Dementia 
patients” 
(n=21) 
AES-S 
“Dementia 
patients” 
(n=21) 
AES-C 
“Depression 
patients” 
(n=21) 
AES-S 
“Depression 
patients” 
(n=21) 
AES (18-Item Version) 
K-S (p-value) 
MeanSD (score) 
Mean+2SD (score) 
Cut-off point (score) 
Median (score) 
Range (score) 
Skewness 
 
1.84 (.002) 
24.25.3 
34.8 
35 
23 
13-44 
1.26 
 
1.55 (.02) 
26.56 
38.6 
39 
26 
18-49 
1.0 
 
 
19.31.1 
21.5 
22 
19 
18-22 
 
 
 
44.712.1 
68.9 
69 
41 
24-64 
 
 
 
34.610.4 
55.4 
56 
33 
20-59 
 
 
 
32.511.6 
55.7 
56 
29 
19-65 
 
 
 
32.810.3 
53.4 
54 
29 
22-56 
 
AES (Short version) 
K-S (p-value) 
MeanSD (score) 
Mean+2SD (score) 
Cut-off point (score) 
Median (score) 
Range (score) 
Skewness 
AES-C-10 
2.28 (.001) 
12.52.6 
17.7 
18 
12 
10-22 
1.40 
AES-S-10 
1.47 (.027) 
14.73.3 
21.3 
22 
14 
10-26 
0.70 
AES-C-10 
 
10.20.4 
11 
11 
10 
10-11 
 
AES-C-10 
 
23.96.6 
37.1 
37 
24 
12-34 
 
AES-S-10 
 
18.45.5 
29.4 
30 
18 
12-30 
 
AES-C-10 
 
15.34.0 
23.3 
24 
15 
10-26 
 
AES-S-10 
 
17.95.4 
28.7 
29 
16 
12-29 
 
 
 
AES-C: Apathy Evaluation Scale-Clinical; AES-S: Apathy Evaluation Scale-Self-rated; AES-C-10: 10-item 
Apathy Evaluation Scale-Clinical-10; AES-S-10: 10-item Apathy Evaluation Scale-Self-rated-10; K-S: 
Kolmogorov-Smirnov test; Mean+2SD: Z-score which is the mean plus two standard deviations. 
 
Metric properties of the AES-S  
From the 156 “healthy participants” we included 143 for analysis of the AES-S. The 
remaining 13 “healthy participants” were not included because they refused to fill in the AES-
S. (Table 1) 
Internal consistency coefficient was high (Cronbach α=.81; Split-half= .60; Between the 18 
items: F(17, 142)= 8.56, p<.01). We computed PCA (Kaiser Rule) with three components and 
no item was excluded. The three components accounted for 42.6% of the variance (Table 2). 
The three components were correlated among each other. AES-S was moderately correlated 
with component 3 and it was highly correlated with components 1 and 2 (Table 3). 
No differences were found in AES-S scale scores between genders (t(141)=1.89, p>.05) 
and among three age groups (F(2,142)=0.41, p>0.05). No correlation was found between 
AES-S scale scores and educational level (r=-0.81, p>.05) was find. 
For the total AES-S scores (Table 5) the cut-off point was 39, thus “healthy participants” 
scoring 39 or more would be considered as apathetic (Six (4.2%) “healthy participants” were 
apathetic). 
Metric properties of the short versions of the AES: AES-C-10 and AES-S-10 (Table 5) 
For the AES-C-10 and the AES-S-10, we performed the same analysis but independently 
from the metric analysis made for AES-C and AES-S, using the “healthy participants” sample 
(n=156). 
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Metric properties of AES-C-10  
Internal consistency coefficient for the AES-C-10 was high (Cronbach α=.70; Split-
half=.79). The PCA (Kaiser rule) with three components explained 58.6% of the variance of 
the 10 items. For AES-C-10, component 1 explained 23.4% of the variance and was 
represented by five items from the 18-item-scale version, namely: item 1 (interested in 
things), 6 (put little effort into things), 10 (someone has to tell what to do), 17 (has initiative) 
and 18 (has motivation). Component 2 explained 18.6% of the variance and was represented 
by three items: item 11 (less concerned about her/himself), 14 (get excited with good things) 
and 15 (accurate understanding of problems). Component 3 explained 16.5% of the variance 
and was represented by two items: item 12 (has friends) and 13 (to be with friends is 
important). Components 1 and 2 were moderately correlated (r=.39, p<.01), but components 1 
and 3 (r=.14, p>.05) and components 2 and 3 (r=.05; p>.05) were not correlated. The AES-C-
10 was positively correlated with the three components (F1: r=.83; F2: r=.66; F3: r=.53; 
p<.01). 
There were no statistical differences in AES-C-10 scale scores between genders 
(t(154)=0.04, p> .05) and among the three age groups (F(2, 155)= 0.33, p>.05). There were 
differences (F(2, 155)=4.55, p<.01; Bonferroni p<.01) among the three educational groups 
(Table 4), with the lowest (</=4 years and 5-9 years of school) educated groups having higher 
cut-off points on the AES-C-10. The cut-off point for the AES-C-10, irrespective of 
educational level, was 18 points. Eleven (7.1%) “healthy participants” scored ≥18 and were 
considered as being apathetic. 
Metric properties of AES-S-10 
Internal consistency coefficient for the AES-S-10 was good (Cronbach α=0.65; Split-
half=0.57). The PCA (Kaiser rule) with three components explained 51.7% of the variance of 
the 10 items. For AES-S-10, component 1 explained 19.8% of the variance and was 
represented by items 1 (interested in things), 17 (has initiative) and 18 (has motivation). 
Component 2 explained 16.1% of the variance and was represented by items 6 (put little effort 
into things), 10 (someone has to tell her/him what to do), 11 (less concerned about 
her/himself), 14 (get excited with good things) and 15 (accurate understanding of problems). 
Component 3 explained 15.7% of the variance and was represented by items 12 (has friends) 
and 13 (to be with friends is important). Component 1 was mildly correlated with component 
2 (r=.35, p<.01) and with component 3 (r=.19, p<.05). Correlation between components 2 and 
3 was not significant (r=.15, p>.05). This AES-S-10 was positively correlated with each of the 
three components (F1: r=.73; F2: r=.83; F3: r=.49; p<.01). 
For AES-S-10 scale scores there were no differences between genders (t(141)=1.89, 
p>.05), among the three age groups (F(2, 142)=0.61, p>.05) or among the three groups of 
educational level (F(2, 142)=0.28, p>.05). The cut-off point for the AES-S-10 was 22 points 
and in our sample of “healthy participants” 5 (3.5%) reported apathy. 
Correlation between scales 
The correlations between the scores in the four versions of the AES showed significant 
moderate to high values (Table 6). 
Considering the clinical versions, the AES-C and the AES-C-10, the two were highly 
correlated meaning that the 10-item short version of the AES-C can easily substitute the AES-
C in the clinical rate of apathy. 
The same high correlation was seen between the two self-rated versions of the AES, the 
AES-S and the AES-S-10, meaning that AES-S-10 can replace the AES-S in the self-rating of 
apathy. 
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Table 6: Correlations between the two versions of the AES and the two versions of 10-item 
of the scales, in the “healthy participants” samples 
 
 
Comparison between “participants” and “patients” samples: AES-C, AES-S, AES-C-10 
AND AES-S-10 (Table 1; Graphic 1) 
Considering the AES, there were differences in: 1) AES-C: patients with “dementia” 
showing the highest mean score, followed by the group of patients with “depression” (F(3, 
237)=82.6, p<=.01; Bonferroni: p<.01). “Dementia patients” scored positively most 
frequently in all items, followed by the group of “depression patients” (Graphic 1); 2) AES-S: 
“healthy participants” showed the lower mean scale score (F(2, 184)=16.8, p<.01; Bonferroni: 
p<.01); 3) AES-C-10: “Dementia patients” showed higher mean scale scores (F(3, 
237)=101.65, p<.01; Bonferroni: p<.01); 4) AES-S-10: “Dementia patients” showed slightly 
higher mean scores compared with “healthy participants” and “elderly participants” (F(2, 
184)=12.97, p<.01; Bonferroni: p<.01). 
 
Graphic 1: AES-C profile of “participants” and “patients”: Percentages of “participants” 
and “patients” scoring positively (Range 4-2 points: “Not at all” to “Somewhat 
characteristic”) in each item. 
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In items 6, 10 and 11 all “elderly participants” scored “Not at all characteristic”, and in items 13, 14, 15, 16, 17 
and 18 all scored “Very characteristic”, representing a percentage of zero “elderly participants” scoring 
positively, in both cases. 
 
DISCUSSION 
 
In this study of metric properties, the AES-C and the AES-S showed good construct 
validity and high internal consistency. The cut-off point of AES-C was 35 points. The cut-off 
point of the AES-S was 39 points. The items that loaded onto the ACP (Kaiser rule) for the 
AES-C and AES-S were quite similar, and both scales were moderately correlated. The short 
clinical-rated (AES-C-10) and self-rated (AES-S-10) short versions of the AES may be used 
instead of the long versions. 
For this study, we included a sample of “healthy participants” of active community-
dwelling Portuguese subjects. In order to have information on independent elderly subjects, 
we included a sample of “elderly participants” aged >60 years old. For a comparison with 
clinical samples, we included “depressive patients” and “demented patients”. Comparisons 
among the four groups showed differences in mean scale scores in the AES-C and in the 
AES-S: “participants” presented lower mean scale scores compared with the two clinical 
samples. The “dementia patients” had the highest means scale scores. These results confirm 
previous publication showing that apathy is frequent in patients with “depression” and in 
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patients with “dementia” (Biancosino, Picardi, Marmai, Biondi, & Grassi, 2010; Clarke, et al., 
2008; 2010; Reyes, 2009). 
Comparing our results with these three studies (Table 7) all reported good internal 
consistency with similar Cronbach α values. Both Chinese and English cut-off points were 
higher compared with the cut-off point in our study, but in the German version cut-off points 
were lower. The differences between our sample of “healthy participants” and the Marin et al. 
(1991) sample of normal controls could be higher motivation in the latter, as they were paid to 
participate in the study. Another difference was that our sample of “healthy participants” was 
more than 10 years younger compared with the other three samples, and had 4.7 mean years 
of educational level more than Marin et al. (1991) normal controls. Based on educational 
level, the cut-off points that we found for the AES-C were higher in “healthy participants” 
with low education level, and were quite similar to the cut-off point that we calculated for the 
Marin et al. (1991) sample. In our study, “healthy participants” with a low educational level 
expressed themselves and were clinically scored in their daily activities and interests more 
frequently as “not characteristic” or as “moderate”, “mildly”. On the other hand, “healthy 
participants” with higher educational levels expressed themselves and were clinically scored 
in their daily activities and interests more frequently as being “very characteristic”. This was 
not the case on the AES-S, i.e. less educated “healthy participants” qualified and quantified 
their motivation, activity, curiosity and emotional attachment just the same as “healthy 
participants” with higher educational levels. Clarke et al. (2007) highlighted the possibility of 
false negatives using the AES-S particularly for patients who have a lack of insight into their 
problems or apathy, which could be present because of the moderate (and not high) 
correlation between AES-C and AES-S. 
 
Table 7: Descriptions of “healthy participants” included in the English, Chinese, German 
and Portuguese studies of the AES-C and AES-S. Internal consistency and cut-off point of 
each version. 
 
 
In the Clarke et al. (2008) publication, older patients with dementia (n=121; age 
mean=73.7, SD=9.4 years old) were apathetic if they scored above 40.5 points for the AES-C, 
and 36.5 points for the AES-S, which are lower than the cut-off point in our sample of 
patients with “dementia”. 
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We also studied the metric properties of a new 10-item short version of the AES clinical 
rate and of a self-rated scale, the AES-C-10 and the AES-S-10, to be used in acute hospital 
settings. The analysis of AES-C-10 (Cronbach α=.70; Split-half=.76) and the AES-S-10 
(Cronbach α=.65; Split-half=.57) showed good construct validity and internal consistency. 
The cut-off point of AES-C-10 was 18 points and the cut-off point of AES-C-10 was 22 
points. 
Lueken et al. (2007) also developed a short version of the AES-C, which is different from 
our short version of the AES-C. We chose and validated 10 items suitable for an acute setting, 
while Lueken et al. chose 10 items and validated a 10-item scale appropriate for demented 
nursing home residents and not an acute hospital setting. Sagen et al (2010) also performed a 
study of the metric properties of a second 10-item version of the AES, in stroke, subarachnoid 
haemorrhage and in psychiatric patients, 4 months after disease onset. Once again, we think 
that this proposal was not suitable for acute hospital settings. A common feature is that both 
were validated in patients and not in healthy participants as we did. 
Our study had some limitations. We did not evaluate a sample of patients diagnosed as 
apathetic by DSM-IV-TR clinical criteria of Personality Disturbances Secondary to a Medical 
Condition on clinical groups of patients. We also did not compare the performance on AES 
with a different validated apathy scale. We should note that there is no other validated scale to 
assess apathy in the Portuguese language. We did not analyze test-retest and inter-rater 
reliability. 
If not detected, silently apathy interferes with individual’s mental health decreasing well 
being and psychosocial involvement (Lamers, Westerhof, Bohlmeijer, ten Klooster, & Keyes, 
2011), which is the main reason for giving special attention. 
In conclusion, the AES-C and the AES-S were proved to be useful to assess apathy in the 
normal Portuguese-speaking population. The shorter versions of these two scales (AES-C-10 
and AES-S-10) would be of value for use in a hospital setting and in such a setting it can be 
used instead of the long-versions. Clearly, the four versions of the AES differentiated healthy 
common people from clinical samples. 
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